Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Description of Joint Population and Assessment of Impact on Health Status of Orencia in Patients With Rheumatoid Arthritis in France. A Database Analysis Based on SFR's ORA Long-term Cohort Study
- Status
- WITHDRAWN
- Phase
- N/A
A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's Syndrome
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Phase 2 Study in Japanese Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly
- Status
- COMPLETED
- Phase
- PHASE2
Safety Sudy of Atazanavir Boosted With Ritonavir in the Treatment of HIV Infection in Pediatric Patients
- Status
- COMPLETED
- Phase
- PHASE4
Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Effectiveness of Biological DMARDs in Elderly Patients With Rheumatoid Arthritis
- Status
- UNKNOWN
- Phase
- N/A
The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection
- Status
- UNKNOWN
- Phase
- N/A
Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events
- Status
- COMPLETED
- Phase
- PHASE3
Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Pattern Of Use Of Belatacept In US Transplant Recipients
- Status
- COMPLETED
- Phase
- N/A
Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)
- Status
- COMPLETED
- Phase
- PHASE3
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up
- Status
- COMPLETED
- Phase
- N/A
Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib
- Status
- COMPLETED
- Phase
- PHASE4
An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Belatacept and Risk of Post-transplant Lymphoproliferative Disorder in US Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- N/A